Literature DB >> 3609756

Eight-year follow-up of central serous chorioretinopathy with and without laser treatment.

R Brancato, A Scialdone, A Pece, G Coscas, M Binaghi.   

Abstract

A long-term retrospective study was conducted on two groups of patients affected with typical central serous chorioretinopathy (CSCR). One group was not treated and the other was treated by direct argon laser photocoagulation. CSCR shows a long-term good prognosis of visual acuity. The visual acuity of laser-treated eyes improves significantly (P less than or equal to 0.05), particularly in single focus cases (P less than or equal to 0.01). Unfortunately, these results cannot be statistically compared to the natural course of the non-treated patients because of the initial inhomogeneity of the two groups. Laser treatment did not produce any long-term complications. The recurrence rate in treated and untreated eyes was similar.

Entities:  

Mesh:

Year:  1987        PMID: 3609756     DOI: 10.1007/bf02175443

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  5 in total

1.  Long-term follow-up of central serous retinopathy.

Authors:  M Nanjiani
Journal:  Trans Ophthalmol Soc U K       Date:  1977-09

Review 2.  [Idiopathic central serous chorioretinopathy].

Authors:  M Binaghi; Y Prevost; G Coscas
Journal:  J Fr Ophtalmol       Date:  1984       Impact factor: 0.818

3.  [Diffuse retinal epitheliopathy and central serous chorioretinopathy].

Authors:  D Cohen; A Gaudric; G Coscas; G Quentel; M Binaghi
Journal:  J Fr Ophtalmol       Date:  1983       Impact factor: 0.818

4.  Direct and indirect laser photocoagulation of central serous choroidopathy.

Authors:  R C Watzke; T C Burton; R F Woolson
Journal:  Am J Ophthalmol       Date:  1979-11       Impact factor: 5.258

5.  Long-term follow-up of central serous chorioretinopathy.

Authors:  C M Gilbert; S L Owens; P D Smith; S L Fine
Journal:  Br J Ophthalmol       Date:  1984-11       Impact factor: 4.638

  5 in total
  12 in total

1.  [Central serous chorioretinopathy (CSC)].

Authors:  H Baraki; N Feltgen; J Roider; H Hoerauf; C Klatt
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

2.  Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy.

Authors:  R Uetani; Y Ito; K Oiwa; K Ishikawa; H Terasaki
Journal:  Eye (Lond)       Date:  2012-05       Impact factor: 3.775

Review 3.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

4.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

5.  Indocyanine green enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy.

Authors:  F Ricci; F Missiroli; F Regine; M Grossi; G Dorin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-17       Impact factor: 3.117

6.  Low-dose aspirin as treatment for central serous chorioretinopathy.

Authors:  Antonio Caccavale; Filippo Romanazzi; Manuela Imparato; Angelo Negri; Anna Morano; Fabio Ferentini
Journal:  Clin Ophthalmol       Date:  2010-08-09

7.  Transpupillary thermotherapy for atypical central serous chorioretinopathy.

Authors:  Ryosuke Kawamura; Hidenao Ideta; Hideyuki Hori; Kenya Yuki; Tsuyoshi Uno; Tatsurou Tanabe; Kazuo Tsubota; Tsutomu Kawasaki
Journal:  Clin Ophthalmol       Date:  2012-01-25

8.  Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial.

Authors:  Myrte B Breukink; Susan M Downes; Giuseppe Querques; Elon H C van Dijk; Anneke I den Hollander; Rocio Blanco-Garavito; Jan E E Keunen; Eric H Souied; Robert E MacLaren; Carel B Hoyng; Sascha Fauser; Camiel J F Boon
Journal:  Trials       Date:  2015-09-21       Impact factor: 2.279

9.  Pattern of Contrast Sensitivity Changes in Acute Central Serous Chorioretinopathy.

Authors:  Preeyachan Lourthai; Patama Bhurayanontachai
Journal:  J Ophthalmol       Date:  2017-12-20       Impact factor: 1.909

10.  Transfoveal Micropulse Laser Treatment of Central Serous Chorioretinopathy within Six Months of Disease Onset.

Authors:  Maciej Gawęcki; Agnieszka Jaszczuk-Maciejewska; Anna Jurska-Jaśko; Małgorzata Kneba; Andrzej Grzybowski
Journal:  J Clin Med       Date:  2019-09-06       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.